Curcumin in Pancreatic Cancer: Enhancing Bioavailability and Supplement Recommendations
https://notebooklm.google.com/notebook/f9ca5fb8-4014-44d1-9849-04f037e4fdbb/audio
This source explores the use of curcumin, the active ingredient in turmeric, as a potential treatment for pancreatic cancer. While curcumin has demonstrated anti-cancer properties in clinical studies, its effectiveness is limited by poor oral bioavailability. The review examines the pharmacokinetic challenges that hinder curcumin’s absorption and systemic exposure, including low solubility and rapid metabolism. Several advanced bioavailability enhancement strategies, such as nanoparticle delivery, liposomal encapsulation (Meriva), and phospholipid complexes, are discussed to improve curcumin’s therapeutic potential. The document presents TenQmin S Plus, a novel formulation using a patented solubilization technology with galactomannan and fenugreek-derived proteins, which is claimed to significantly enhance curcumin absorption compared to standard formulations. The text summarizes data on the effectiveness of various methods to improve absorption, including a claim that the newest formulations of curcumin can be absorbed as much as 1,600 times better than standard curcumin.
